An interventional study of ED-SMART intervention and Substance use information in Substance Use (Drugs, Alcohol), sponsored by Purdue University. Enrolling by invitation at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-23.
Sponsored by Purdue University · Not applicable, Interventional, and Treatment
The purpose of this research study is to learn if an emergency department screening and telehealth intervention reduces substance use among individuals receiving emergency department treatment at The Ohio State University Wexner Medical Center.
2,238 studies on the registry are indexed under Substance-Related Disorders; 409 are open to participants now.
This study's planned enrollment of 650 is above the median of 108 across 1,840 interventional studies indexed under Substance-Related Disorders.
Browse Substance-Related Disorders studies →Purdue University is the lead sponsor of 175 studies on the registry; 21 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
The ED-SMART intervention includes: (i) a brief (approximately 15 minutes) counseling session in the emergency department and (ii) five, monthly brief counseling sessions (approximately 15 to 30 minutes) delivered by telehealth. These sessions will focus on creating individualized strategies to help participants reach their alcohol and substance use reduction goals.
Behavioral: ED-SMART intervention
The substance use information condition will receive printed health information covering information about substance use (e.g., definitions, hazards, potential for addiction, injury, and other consequences). Staff will also discuss ways to utilize primary care or establish care with a primary care provider to provide ongoing follow-up.
Behavioral: Substance use information
The ED-SMART intervention will include: (i) a brief (approximately 15 minutes) counseling session in the emergency department and (ii) five, monthly brief counseling sessions (approximately 15 to 30 minutes) delivered by telehealth. These sessions will focus on creating individualized strategies to help participants reach their alcohol and substance use reduction goals
The substance use information condition will receive printed health information covering information about substance use (e.g., definitions, hazards, potential for addiction, injury, and other consequences). Research staff will also discuss ways to utilize primary care or establish care with a primary care provider to provide ongoing follow-up.
Self-reported substance use
Self-reported substance use frequency
Time frame: From baseline to the sixth month follow-up assessment
Self-reported substance use quantity
Self-reported substance use quantity for each substance
Time frame: From baseline to the six month follow-up
Incidence of positive substance use disorder screen
Incidence of positive substance use disorder screen as measured by the NIDA Modified ASSIST or AUDIT
Time frame: From baseline to the six month follow-up
Toxicology assays for substance use
Proportion with positive toxicology assay for substance use
Time frame: From baseline to the six month follow-up assessment
Self-reported healthcare utilization
Self-reported healthcare utilization
Time frame: Baseline to the six month follow-up assessment
Fatal and non-fatal overdose
Frequency of fatal and non-fatal overdose
Time frame: Baseline to the six month follow-up assessment
Plan to share: Undecided
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.